Research is being conducted on the role of autophagy in cancer cells' resistance to doxorubicin, a chemotherapy drug. Studies are exploring various mechanisms and pathways involved in this resistance, including the potential roles of specific transcription factors, long non-coding RNAs, and cellular processes like mitophagy and ferroptosis. The findings may lead to new therapeutic perspectives and targets for overcoming drug resistance in different types of cancer.